anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
slides · global inventory

Disclaimer

Component collection for the active corpus filters, with each row opening the slide detail view.

Search Insights JSON Unlock
Matching slides 41,127
Current window 9,571-9,600
Pages 1,371
Rows per page 30
Component: Disclaimerclear collectionreset all
18 30 60

Component

9,571-9,600 of 41,127

filter-aware
78
Form ADV disclosure page.asset and wealth management mn · Goldman Sachs
Consulting deck Equity research Beat · Evidence & Proof1 hit
92
Page 92 of a Form ADV document.asset and wealth management mn · Goldman Sachs
Consulting deck Equity research Beat · Evidence & Proof1 hit
97
This is a standard legal disclosure page from a Form ADV filing.asset and wealth management mn · Goldman Sachs
Consulting deck Equity research Beat · Evidence & Proof1 hit
105
Form ADV disclosure page.asset and wealth management mn · Goldman Sachs
Consulting deck Equity research Beat · Impact & Next Steps1 hit
110
This is a page from a Form ADV regulatory filing.asset and wealth management mn · Goldman Sachs
Consulting deck Equity research Beat · Impact & Next Steps1 hit
112
Form ADV page 112.asset and wealth management mn · Goldman Sachs
Consulting deck Equity research Beat · Impact & Next Steps1 hit
113
Form ADV disclosure page 113.asset and wealth management mn · Goldman Sachs
Consulting deck Equity research Beat · Impact & Next Steps1 hit
114
Form ADV page 114asset and wealth management mn · Goldman Sachs
Consulting deck Equity research Beat · Impact & Next Steps1 hit
118
Form ADV disclosure page 118.asset and wealth management mn · Goldman Sachs
Consulting deck Equity research Beat · Impact & Next Steps1 hit
120
This is a standard Form ADV disclosure page.asset and wealth management mn · Goldman Sachs
Consulting deck Equity research Beat · Impact & Next Steps1 hit
125
Form ADV page 125.asset and wealth management mn · Goldman Sachs
Consulting deck Equity research Beat · Impact & Next Steps1 hit
127
This is a standard regulatory disclosure page from a Form ADV document.asset and wealth management mn · Goldman Sachs
Consulting deck Equity research Beat · Impact & Next Steps1 hit
128
Page 128 of a Form ADV document.asset and wealth management mn · Goldman Sachs
Consulting deck Equity research Beat · Impact & Next Steps1 hit
129
Page 129 of a Form ADV document.asset and wealth management mn · Goldman Sachs
Consulting deck Equity research Beat · Impact & Next Steps1 hit
130
Page 130 of a Form ADV document.asset and wealth management mn · Goldman Sachs
Consulting deck Equity research Beat · Impact & Next Steps1 hit
134
Form ADV page 134.asset and wealth management mn · Goldman Sachs
Consulting deck Equity research Beat · Impact & Next Steps1 hit
156
This is a regulatory disclosure document (Form ADV) containing specific fee tiers, minimum annual fees, and tracking error assumptions.asset and wealth management mn · Goldman Sachs
Consulting deck Equity research 1 hit
157
This is a regulatory disclosure document (Form ADV) listing tiered fee structures based on assets under management.asset and wealth management mn · Goldman Sachs
Consulting deck Equity research 1 hit
165
The slide presents fee structures for U.S. Equity and Global/Non-U.S. Equity strategies, including specific footnotes regarding tracking error assumptions.asset and wealth management mn · Goldman Sachs
Consulting deck Equity research 1 hit
182
This is a standard legal disclosure page from an ERISA or investment advisory presentation.asset and wealth management mn · Goldman Sachs
Consulting deck Equity research 1 hit
01
Slide 1
Eyepoint Goldman Sachs June 10 2025Eyepoint Goldman Sachs June 10 2025 · EyePoint Pharmaceuticals
Consulting deck Equity research 1 hit
02
Eyepoint Goldman Sachs June 10 2025Eyepoint Goldman Sachs June 10 2025 · EyePoint Pharmaceuticals
Consulting deck Equity research 1 hit
03
The slide uses a list of callout boxes to highlight key company milestones and financial status.Eyepoint Goldman Sachs June 10 2025 · EyePoint Pharmaceuticals
Consulting deck Equity research 1 hit
04
The slide uses a timeline-based visualization to show the status of drug development programs.Eyepoint Goldman Sachs June 10 2025 · EyePoint Pharmaceuticals
Consulting deck Equity research 1 hit
05
Eyepoint Goldman Sachs June 10 2025Eyepoint Goldman Sachs June 10 2025 · EyePoint Pharmaceuticals
Consulting deck Equity research 1 hit
09
The slide uses a table-like structure to map clinical trials (DAVIO, DAVIO 2, PAVIA, VERONA) to patient counts and key outcomes.Eyepoint Goldman Sachs June 10 2025 · EyePoint Pharmaceuticals
Consulting deck Equity research 1 hit
10
Eyepoint Goldman Sachs June 10 2025Eyepoint Goldman Sachs June 10 2025 · EyePoint Pharmaceuticals
Consulting deck Equity research 1 hit
11
The slide uses a four-column layout to present strategic advantages.Eyepoint Goldman Sachs June 10 2025 · EyePoint Pharmaceuticals
Consulting deck Equity research 1 hit
14
The slide uses a timeline framework to track trial progress from Jan 2025 to mid-2026.Eyepoint Goldman Sachs June 10 2025 · EyePoint Pharmaceuticals
Consulting deck Equity research 1 hit
15
Includes company logo and copyright information.Eyepoint Goldman Sachs June 10 2025 · EyePoint Pharmaceuticals
Consulting deck Equity research 1 hit